Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyperus rotundus oral product in mild to moderate Alzheimer's disease
IRCT20220625055269N1Phase 2Completed
- Sponsor
- Shahed University
- Start
- Mar 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cyperus rotundus in Alzheimer's disease (AD), sponsored by Shahed University. Started Mar 2023; status: completed.
02
Drugs
cyperus rotundus
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on IRCT20220625055269N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220625055269N1.